The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis

Cell Reports
J Patrick MurphyShashi Gujar

Abstract

NAD+ is a key metabolic redox cofactor that is regenerated from nicotinamide through the NAD+ salvage pathway. Here, we find that inhibiting the NAD+ salvage pathway depletes serine biosynthesis from glucose by impeding the NAD+-dependent protein, 3-phosphoglycerate dehydrogenase (PHGDH). Importantly, we find that PHGDHhigh breast cancer cell lines are exquisitely sensitive to inhibition of the NAD+ salvage pathway. Further, we find that PHGDH protein levels and those of the rate-limiting enzyme of NAD+ salvage, NAMPT, correlate in ER-negative, basal-like breast cancers. Although NAD+ salvage pathway inhibitors are actively being pursued in cancer treatment, their efficacy has been poor, and our findings suggest that they may be effective for PHGDH-dependent cancers.

Citations

Aug 9, 2019·The Journal of Clinical Investigation·W Brian DaltonBen Ho Park
Nov 7, 2019·The Journal of Cell Biology·Miguel Reina-CamposJorge Moscat
Oct 11, 2019·Nature Metabolism·Frances F DiehlMatthew G Vander Heiden
Mar 13, 2019·International Journal of Molecular Sciences·Renata Novak KujundžićKoraljka Gall Trošelj
Aug 22, 2020·World Journal of Gastroenterology : WJG·Gabriel Benyomo MpillaAsfar Sohail Azmi
Jan 12, 2019·Frontiers in Oncology·Keisuke YakuTakashi Nakagawa
Sep 29, 2019·Expert Reviews in Molecular Medicine·Judith E Unterlass, Nicola J Curtin
Oct 2, 2020·Current Opinion in Hematology·Erica L BravermanCraig A Byersdorfer
May 19, 2020·The Journal of Clinical Investigation·W Brian Dalton
Dec 29, 2020·Cell Metabolism·Sangmoo JeongKayvan R Keshari
Feb 8, 2020·Cancer Letters·Albert M Li, Jiangbin Ye
Mar 24, 2021·European Journal of Medicinal Chemistry·Jia-Ying ZhaoPing Tian
Nov 20, 2020·Cell·Karsten KrugUNKNOWN Clinical Proteomic Tumor Analysis Consortium
May 16, 2020·Cancer Cell·Mylène Tajan, Karen H Vousden
May 25, 2021·Molecular & Cellular Oncology·Richa Rathore, Brian Van Tine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.